The activity of BCR/ABL can be enhanced through SFK-mediated phosphorylation within the activation loop of ABL, which was found to increase the ABL kinase activity in the progression of CML and Ph+ ALL. This evidence concerns the gene BCR and chronic myelogenous leukemia, BCR-ABL1 positive.